Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study
Titel:
Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study
Auteur:
Garassino, Marina Chiara Cho, Byoung-Chul Kim, Joo-Hang Mazières, Julien Vansteenkiste, Johan Lena, Hervé Jaime, Jesus Corral Gray, Jhanelle E. Powderly, John Chouaid, Christos Bidoli, Paolo Wheatley-Price, Paul Park, Keunchil Soo, Ross A. Poole, Lynne Wadsworth, Catherine Dennis, Phillip A. Rizvi, Naiyer A.